L04AG Monoclonal antibodies Monoclonal antibodies Monoclonal antibodies Monoclonal antibodies L4
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 · nombre de respaldo (en) 来源:维基百科 · CC BY-SA 4.0 · 回退名 (en) 來源:維基百科 · CC BY-SA 4.0 · 回退名 (en)
ATC level L4 · Search this class · Consumer categories
Active ingredients in this class
13 active ingredients 13 principios activos 13 个活性成分 13 個有效成分
Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Belimumab
L04AG04active US GB CA SG CN · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA SG CN ES MX TW EU FR · unknown AU HK - Ofatumumab
L04AG12active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES MX TW EU FR · unknown HK - Vedolizumab
L04AG05active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES MX TW EU FR · unknown HK - Natalizumab
L04AG03active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES MX TW EU FR · unknown HK - Alemtuzumab
L04AG06active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Ocrelizumab
L04AG08active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX EU FR · unknown HK - Anifrolumab
L04AG11active US CA AU ES MX · and 5 more y 5 más 另有 5 个 另有 5 個
active US CA AU ES MX TW EU FR · unknown HK - Teprotumumab
L04AG13active US GB CA SG TW · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA SG TW EU · discontinued ES · unknown AU HK - Inebilizumab
L04AG10active US CA ES TW EU · and 3 more y 3 más 另有 3 个 另有 3 個
active US CA ES TW EU FR · unknown AU - Ublituximab
L04AG14active US GB AU ES EU
active US GB AU ES EU - Efalizumab
L04AG02active GB · and 6 more y 6 más 另有 6 个 另有 6 個
active GB · discontinued CA · withdrawn EU · unknown MX - Muromonab-Cd3
L04AG01active GB · and 2 more y 2 más 另有 2 个 另有 2 個
active GB · discontinued CA - 罗普司亭N01
L04AGSalt form: 替妥尤单抗N01
替妥尤单抗N01active CN
active CN
By dosage form, across markets
Only ingredients with a recorded ATC class are listed (6,009 of 12,637).